LakeShore Biopharma Co (FRA:H6Z0) NonCurrent Deferred Liabilities: €2.07 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:H6Z0 LakeShore Biopharma Co Ltd FRA:H6Z0
17 GF Score
Price €0.67
View Full Analysis

What is LakeShore Biopharma Co NonCurrent Deferred Liabilities?

LakeShore Biopharma Co FRA:H6Z0 17 NonCurrent Deferred Liabilities is €2.07 Mil as of Mar. 2025. GuruFocus rates FRA:H6Z0 with a GF Score™ of 17/100.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

LakeShore Biopharma Co's non-current deferred liabilities for the quarter that ended in Mar. 2025 was €2.07 Mil.

LakeShore Biopharma Co NonCurrent Deferred Liabilities Related Terms

LakeShore Biopharma Co NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co NonCurrent Deferred Liabilities Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
NonCurrent Deferred Liabilities
3.98 4.30 3.20 2.59 2.07

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only 3.20 2.88 2.59 2.16 2.07
FRA:H6Z0
17GF Score
LakeShore Biopharma Co Ltd FRA:H6Z0
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of €2.07 Mil mean?
LakeShore Biopharma Co (FRA:H6Z0) has a NonCurrent Deferred Liabilities of €2.07 Mil as of Mar. 2025. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's NonCurrent Deferred Liabilities too high?
LakeShore Biopharma Co's current NonCurrent Deferred Liabilities is €2.07 Mil. Overall, LakeShore Biopharma Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does LakeShore Biopharma Co's NonCurrent Deferred Liabilities compare to ACUT and PPCB?
LakeShore Biopharma Co's NonCurrent Deferred Liabilities of €2.07 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Biotechnology company?
A good NonCurrent Deferred Liabilities depends on the Biotechnology industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current NonCurrent Deferred Liabilities is €2.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (FRA:H6Z0) has a current NonCurrent Deferred Liabilities of €2.07 Mil. The current NonCurrent Deferred Liabilities is €2.07 Mil. LakeShore Biopharma Co's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For LakeShore Biopharma Co (FRA:H6Z0), the current NonCurrent Deferred Liabilities is €2.07 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Other Exchanges LSBCF:USA
Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
17GF Score

Get the complete analysis for FRA:H6Z0

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.67
Price